blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1677821

EP1677821 - A METHOD FOR INCREASING CD8+ CYTOTOXIC T CELL REPONSES AND FOR TREATING MULTIPLE SCLEROSIS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.01.2014
Database last updated on 14.11.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU, LU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
BAYLOR COLLEGE OF MEDICINE
One Baylor Plaza
Houston, TX 77030 / US
[2006/28]
Inventor(s)01 / ZANG, Ying, C., Q.
2219 Parkview Lane
Missouri City, TX 77459 / US
 [2006/28]
Representative(s)Walton, Seán Malcolm
Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2013/09]Walton, Seán Malcolm
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Former [2007/43]Walton, Seán Malcolm
Mewburn Ellis LLP York House, 23 Kingsway
London WC2B 6HP / GB
Former [2006/28]Derks, Wilbert, et al
Howrey LLP P.O. Box 94361
1090 GJ Amsterdam / NL
Application number, filing date04795590.118.10.2004
[2006/28]
WO2004US34448
Priority number, dateUS20030512212P17.10.2003         Original published format: US 512212 P
[2006/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005037309
Date:28.04.2005
Language:EN
[2005/17]
Type: A1 Application with search report 
No.:EP1677821
Date:12.07.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 28.04.2005 takes the place of the publication of the European patent application.
[2006/28]
Type: B1 Patent specification 
No.:EP1677821
Date:27.02.2013
Language:EN
[2013/09]
Search report(s)International search report - published on:EP28.04.2005
ClassificationIPC:A61K39/00, C12N5/00
[2012/41]
CPC:
A61K39/0008 (EP,US); A61K39/4611 (EP,US); A61K39/4621 (EP,US);
A61K39/46433 (EP,US); A61K39/46482 (EP,US); A61P25/00 (EP);
A61P37/00 (EP); C12N5/0636 (EP,US) (-)
Former IPC [2006/28]A61K39/00, C12N5/06
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/28]
TitleGerman:VERFAHREN ZUR VERSTÄRKUNG DER CD8+ ZYTOTOXISCHEN T-ZELL-ANTWORTEN UND ZUR BEHANDLUNG VON MULTIPLER SKLEROSE[2006/28]
English:A METHOD FOR INCREASING CD8+ CYTOTOXIC T CELL REPONSES AND FOR TREATING MULTIPLE SCLEROSIS[2006/28]
French:PROCEDE POUR AUGMENTER DES REPONSES DE LYMPHOCYTES T CYTOTOXIQUES CD8+ ET POUR TRAITER UNE SCLEROSE EN PLAQUES[2006/28]
Entry into regional phase17.05.2006National basic fee paid 
17.05.2006Designation fee(s) paid 
17.05.2006Examination fee paid 
Examination procedure17.05.2006Examination requested  [2006/28]
04.05.2007Despatch of a communication from the examining division (Time limit: M06)
22.11.2007Reply to a communication from the examining division
02.07.2009Despatch of a communication from the examining division (Time limit: M06)
18.02.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
28.04.2010Reply to a communication from the examining division
30.05.2012Cancellation of oral proceeding that was planned for 12.06.2012
12.06.2012Date of oral proceedings (cancelled)
07.09.2012Communication of intention to grant the patent
07.01.2013Fee for grant paid
07.01.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.05.2007
Opposition(s)28.11.2013No opposition filed within time limit [2014/06]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
28.04.2010Request for further processing filed
28.04.2010Full payment received (date of receipt of payment)
22.11.2007Request for further processing filed
22.11.2007Full payment received (date of receipt of payment)
Request granted
04.12.2007Decision despatched
Fees paidRenewal fee
17.05.2006Renewal fee patent year 03
23.10.2007Renewal fee patent year 04
21.04.2009Renewal fee patent year 05
20.10.2009Renewal fee patent year 06
25.10.2010Renewal fee patent year 07
11.10.2011Renewal fee patent year 08
11.10.2012Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
31.10.200805   M06   Fee paid on   21.04.2009
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.10.2004
AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
MC27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
TR27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
PT27.06.2013
IE18.10.2013
LU18.10.2013
CH31.10.2013
LI31.10.2013
[2015/34]
Former [2015/32]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
MC27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
TR27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
PT27.06.2013
IE18.10.2013
CH31.10.2013
LI31.10.2013
Former [2014/48]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
MC27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
PT27.06.2013
IE18.10.2013
CH31.10.2013
LI31.10.2013
Former [2014/34]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
MC27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
PT27.06.2013
CH31.10.2013
LI31.10.2013
Former [2014/25]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
MC27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
PT27.06.2013
Former [2014/03]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
PT27.06.2013
Former [2013/52]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
PT27.06.2013
Former [2013/49]AT27.02.2013
BE27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
PT27.06.2013
Former [2013/48]AT27.02.2013
BE27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
NL27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
PT27.06.2013
Former [2013/40]AT27.02.2013
BE27.02.2013
FI27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
PT27.06.2013
Former [2013/38]AT27.02.2013
BE27.02.2013
FI27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
Former [2013/37]AT27.02.2013
FI27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
Former [2013/36]AT27.02.2013
PL27.02.2013
SE27.02.2013
BG27.05.2013
ES07.06.2013
Former [2013/34]SE27.02.2013
BG27.05.2013
Cited inInternational search[A]WO02092773  (ORTHO MCNEIL PHARM INC [US]);
 [DY]WO03024393  (OPEXA PHARMACEUTICALS INC [US], et al);
ExaminationWO2005037309
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.